Medicines Discovery Catapult’s Post

PACE - Addressing the global threat of Antimicrobial Resistance. MDC, Innovate UK and LifeArc joined forces to create PACE-AMR (Pathways to Antimicrobial Clinical Efficacy), a £30m initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. Launched in October 2023, PACE aims to support early-stage innovation in AMR, driving the development of new tests and treatments to tackle deadly infections. Follow PACE-AMR Visit https://hubs.li/Q02MkThH0 #AntimicrobialResistance #AMR

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics